Document is current

Article History

Received: 28 October 2020

Revised: 28 October 2020

Accepted: 6 November 2020

First Online: 16 November 2020

Compliance with ethical standards

:

: Aditya Uppuluri, MD, does not have any financial disclosures, conflicts of interest, or competing interests.Sohil Bhagat, BS, does not have any financial disclosures, conflicts of interest, or competing interests.Marco A. Zarbin, MD, PhD, is a consultant for Genentech/Roche, Novartis Pharma AG, Frequency Therapeutics, IVERIC bio, Ophthotech, and Healios KK. He is a stockholder for Frequency Therapeutics, IVERIC bio, and NVasc. He is a speaker for IRIDEX. He is the Co-founder of NVasc.Neelakshi Bhagat, MD, MPH, does not have any financial disclosures, conflicts of interest, or competing interests.

: Because this study uses deidentified data from a national dataset, the Institutional Review Board deemed that this study was exempt from review.

: All authors have provided consent to participate in the study.

: All authors have provided consent for this manuscript to be submitted for publication.

: Code for this project was written by the co-authors in IBM SPSS 23 and R package version 3.4.3.